Markets

Monday 6/17 Insider Buying Report: ITCI, CNR

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy — they expect to make money. So let's look at two noteworthy recent insider buys.

At Intra-Cellular Therapies (ITCI), a filing with the SEC revealed that on Wednesday, Director Christopher D. Alafi purchased 170,000 shares of ITCI, for a cost of $11.73 each, for a total investment of $1.99M. Alafi was up about 18.9% on the buy at the high point of today's trading session, with ITCI trading as high as $13.95 in trading on Monday. Intra-Cellular Therapies is trading up about 10.8% on the day Monday. Before this latest buy, Alafi made one other purchase in the past year, buying $1.26M shares for a cost of $12.56 a piece.

And at Cornerstone Building Brands (CNR), there was insider buying on Thursday, by CEO James S. Metcalf who purchased 100,000 shares at a cost of $4.45 each, for a total investment of $444,580. This buy marks the first one filed by Metcalf in the past year. Cornerstone Building Brands is trading up about 6.5% on the day Monday. So far Metcalf is in the green, up about 16.1% on their buy based on today's trading high of $5.16.

VIDEO: Monday 6/17 Insider Buying Report: ITCI, CNR

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

ITCI CNR

Other Topics

Stocks

Latest Markets Videos

    BNK Invest

    BNK Invest Inc. provides investment services and information. BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. BNK Invest caters to investing firms and individual investors internationally.

    Learn More